Book a Meeting

Anti-GPR64 Antibody, Non-Fucosylated (BioBet-535ZP) (CAT#: BioBet-535ZP) Datasheet

Target
GPR64
Isotype
IgG
Description
ADCC-Enhanced anti-GPR64 (GPR64-20) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Antibody Indication
Cancer; Ovarian Cancer
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced GPR64 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
ADGRG2
Full Name
G protein-coupled receptor 64
Background
This gene encodes a member of the G protein-coupled receptor family described as an epididymis-specific transmembrane protein. The encoded protein may be proteolytically processed as it contains a motif shown to be a protein scission motif in some members of this family (PMID: 11973329). Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative Names
GPR64; G protein-coupled receptor 64; HE6; EDDM6; TM7LN2; G-protein coupled receptor 64; epididymal protein 6; human epididymis-specific protein 6; G protein-coupled receptor, epididymis-specific (seven transmembrane family)
Gene ID
Cellular Localization
Plasma membrane
Involvement in Disease
Diseases associated with ADGRG2 include Vas Deferens, Congenital Bilateral Aplasia Of, X-Linked and Vas Deferens, Congenital Bilateral Aplasia Of.
Related Pathways
Its related pathways are GPCRs, Class B Secretin-like.
Function
Orphan receptor. Could be involved in a signal transduction pathway controlling epididymal function and male fertility. May regulate fluid exchange within epididymis.
Post-translational modifications
1.Proteolytically cleaved into 2 subunits, an extracellular subunit and a seven-transmembrane subunit 2.Modification sites at PhosphoSitePlus 3.Highly glycosylated 4.Glycosylation at Asn44, Asn85, Asn111, Asn99, Asn117, Asn144, Asn162, Asn186, Asn194, Thr268, Ser271, Thr277, Asn357, Asn370, Asn435, Asn438, Asn456, Asn461, Asn597, Asn528, Asn542, Asn547, Asn551, and Asn857
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
GPR64-20
Host
Human
Species Reactivity
Human
Description
GPR64 antibody may be used for diagnosis or treatment of cancer, especially ovarian cancer, Ewing's sarcoma, uterine cancer, and other GPR64 expressing tumor types.
Antibody Indication
Cancer; Ovarian Cancer

Cancer; Ovarian Cancer

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.